Compounds > olomoucine

olomoucine and Lung Neoplasms

olomoucine has been researched along with Lung Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Díaz, E; Guzmán, A; Martínez-Urbina, MA; Ramírez Apan, MT; Vargas, O; Ventura Gallegos, JL; Vilchis-Reyes, MA; Zentella, A1
Cwiertka, K; Dzubak, P; Hajduch, M; Korinkova, G; Paprskarova, M1
Kuijpers, HJ; Ramaekers, FC; Reutelingsperger, CP; Schutte, B; van Engeland, M1
Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M1
Guimond, A; O'Connor-McCourt, MD; Zwaagstra, JC1

Other Studies

5 other study(ies) available for olomoucine and Lung Neoplasms

ArticleYear
6-Substituted 2-(N-trifluoroacetylamino)imidazopyridines induce cell cycle arrest and apoptosis in SK-LU-1 human cancer cell line.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Fluorine; Humans; Imidazoles; Lung Neoplasms; Molecular Structure; Pyridines

2010
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
    Neoplasma, 2010, Volume: 57, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Cycle; Cyclin-Dependent Kinases; Flow Cytometry; Humans; Kinetin; Lung Neoplasms; Protein Kinase Inhibitors; Purines; Radiation-Sensitizing Agents; Roscovitine; Tumor Cells, Cultured; X-Rays

2010
Plasma membrane alterations and cytoskeletal changes in apoptosis.
    Experimental cell research, 1997, Sep-15, Volume: 235, Issue:2

    Topics: Actins; Annexin A5; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Chromatin; Cytoskeleton; Ethylmaleimide; Humans; Keratins; Kinetin; Lung Neoplasms; Neuroblastoma; Phosphatidylserines; Purines; Roscovitine; Tetradecanoylphorbol Acetate; Tubulin; Tumor Cells, Cultured; Vimentin

1997
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
    Experimental cell research, 1997, Oct-10, Volume: 236, Issue:1

    Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured

1997
Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest.
    Experimental cell research, 2000, Jul-10, Volume: 258, Issue:1

    Topics: Activin Receptors, Type I; Animals; Cell Cycle; Cell Line; Cell Membrane; Cell Nucleus; Cyclin-Dependent Kinases; Endoplasmic Reticulum; Enzyme Inhibitors; Gene Expression Regulation; Golgi Apparatus; Green Fluorescent Proteins; Humans; Kinetin; Luminescent Proteins; Lung Neoplasms; Mink; Protein Serine-Threonine Kinases; Purines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Recombinant Fusion Proteins; Respiratory Mucosa; Signal Transduction; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured

2000